Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: This study evaluates how AI enhances EHR efficiency by comparing a lung cancer-specific LLM with general-purpose models (DeepSeek, GPT-3.5) and clinicians across expertise levels, assessing accuracy and completeness in complex lung cancer pathology documentation and task load changes pre-/post-AI implementation.

Methods: This study analyzed 300 lung cancer cases (Shanghai Chest Hospital) and 60 TCGA cases, split into training/validation/test sets. Ten clinicians (varying expertise) and three AI models (GPT-3.5, DeepSeek, lung cancer-specific LLM) generated pathology reports. Accuracy/completeness were evaluated against LeapFrog/Joint Commission/ACS standards (non-parametric tests); task load changes pre/post-AI implementation were assessed via NASA-TLX (paired -tests,  < 0.05).

Results: This study analyzed 1,390 structured pathology databases: 1,300 from 100 Chinese cases (generated by 10 clinicians and three LLMs) and 90 from 30 TCGA English reports. The lung cancer-specific LLM outperformed nurses, residents, interns, and general AI models (DeepSeek, GPT-3.5) in lesion/lymph node analysis and pathology extraction for Chinese records ( < 0.05), with total scores slightly below chief physicians. In English reports, it matched mainstream AI in lesion analysis ( > 0.05) but excelled in lymph node/pathology metrics ( < 0.05). Task load scores decreased by 38.3% post-implementation (413.90 ± 78.09 vs. 255.30 ± 65.50,  = 26.481,  < 0.001).

Conclusion: The fine-tuned lung cancer LLM outperformed non-chief physicians and general LLMs in accuracy/completeness, significantly reduced medical staff workload ( < 0.001), with future optimization potential despite current limitations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12411430PMC
http://dx.doi.org/10.3389/fmed.2025.1618858DOI Listing

Publication Analysis

Top Keywords

lung cancer
12
task load
12
accuracy completeness
8
deepseek gpt-35
8
lung cancer-specific
8
cancer-specific llm
8
load changes
8
lung
5
comparative analysis
4
analysis accuracy
4

Similar Publications

Purpose: mutations are classically seen in non-small cell lung cancers (NSCLCs), and EGFR-directed inhibitors have changed the therapeutic landscape in patients with -mutated NSCLC. The real-world prevalence of -mutated ovarian cancers has not been previously described. We aim to determine the prevalence of pathogenic or likely pathogenic mutations in ovarian cancer and describe a case of -mutated metastatic ovarian cancer with a durable response to osimertinib, an EGFR-directed targeted therapy.

View Article and Find Full Text PDF

Reply to: Comments on the Study of Outcomes After Radiation for Oligoprogressive Disease Sites in Patients With -Mutant Lung Cancer.

JCO Precis Oncol

September 2025

Monica F. Chen, MD, Division of Solid Tumor Oncology, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, Daniel Gomez, MD, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, and Helena A. Yu, MD, Division of Solid Tumor Oncology, Depart

View Article and Find Full Text PDF

Objectives: The 9th edition of the Tumor, Node, Metastasis (TNM-9) lung cancer classification is set to replace the 8th edition (TNM-8) starting in 2025. Key updates include the splitting of the mediastinal nodal category N2 into single- and multiple-station involvement, as well as the classification of multiple extrathoracic metastatic lesions as involving a single organ system (M1c1) or multiple organ systems (M1c2). This study aimed to assess how the TNM-9 revisions affect the final staging of lung cancer patients and how these changes correlate with overall survival (OS).

View Article and Find Full Text PDF